Investigation of a recent rise of dual amantadineresistance mutations in the influenza A M2 sequence

BMC Genetics

Volumn 16, Issue , 2015, Pages

  Durrant, Matthew G ^a   Eggett, Dennis L ^a   Busath, David D ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMINO ACID; PROTEIN M2; M2 PROTEIN, INFLUENZA A VIRUS; MATRIX PROTEIN;

AMINO ACID SEQUENCE; ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC VARIABILITY; INFLUENZA A M2 GENE; INFLUENZA A VIRUS; NONHUMAN; PIG; VIRUS GENE; VIRUS ISOLATION; VIRUS MUTATION; ANIMAL; CLASSIFICATION; DRUG EFFECTS; GENETICS; ORTHOMYXOVIRUS INFECTION; POINT MUTATION; SWINE DISEASE; UNITED STATES; VETERINARY; VIROLOGY;

AMANTADINE; ANIMALS; DRUG RESISTANCE, VIRAL; INFLUENZA A VIRUS; MIDWESTERN UNITED STATES; ORTHOMYXOVIRIDAE INFECTIONS; POINT MUTATION; SWINE; SWINE DISEASES; VIRAL MATRIX PROTEINS;

EID: 84989170891     PISSN: None     EISSN: 14712156     Source Type: Journal    
DOI: 10.1186/1471-2156-16-S2-S3     Document Type: Article

References (19)

1. Gubareva LV, Trujillo AA, Okomo-Adhiambo M, Mishin VP, Deyde VM, Sleeman K, Nguyen HT, Sheu TG, Garten RJ, Shaw MW, et al: Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro. Antiviral therapy 2010, 15(8):1151-1159.
2. Nelson MI, Simonsen L, Viboud C, Miller MA, Holmes EC: The origin and global emergence of adamantane resistant A/H3N2 influenza viruses. Virology 2009, 388(2):270-278.
3. Wang J, Wu Y, Ma C, Fiorin G, Pinto LH, Lamb RA, Klein ML, Degrado WF: Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus. Proceedings of the National Academy of Sciences of the United States of America 2013, 110(4):1315-1320.
4. Torres E, Fernández R, Miquet Sp, Font-Bardia M, Vanderlinden E, Naesens L, Vázquez S: Synthesis and anti-influenza A virus activity of 2,2-dialkylamantadines and related compounds. ACS Med Chem Lett 2012, 3:1065-1069.
5. Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH: The molecular basis of the specific anti-influenza action of amantadine. The EMBO journal 1985, 4(11):3021-3024.
6. Furuse Y, Suzuki A, Oshitani H: Large-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance. Antimicrobial agents and chemotherapy 2009, 53(10):4457-4463.
7. Krumbholz A, Schmidtke M, Bergmann S, Motzke S, Bauer K, Stech J, Durrwald R, Wutzler P, Zell R: High prevalence of amantadine resistance among circulating European porcine influenza A viruses. The Journal of general virology 2009, 90(Pt 4):900-908.
8. Garcia V, Aris-Brosou S: Comparative dynamics and distribution of influenza drug resistance acquisition to protein m2 and neuraminidase inhibitors. Molecular biology and evolution 2014, 31(2):355-363.
9. Abed Y, Goyette N, Boivin G: Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations. Antimicrobial agents and chemotherapy 2005, 49(2):556-559.
10. Bowman AS, Nelson SW, Page SL, Nolting JM, Killian ML, Sreevatsan S, Slemons RD: Swine-to-human transmission of influenza A(H3N2) virus at agricultural fairs, Ohio, USA, 2012. Emerging infectious diseases 2014, 20(9):1472-1480.
11. Ma W, Kahn RE, Richt JA: The pig as a mixing vessel for influenza viruses: Human and veterinary implications. Journal of molecular and genetic medicine: an international journal of biomedical research 2008, 3(1):158-166.
12. Sharma M, Yi M, Dong H, Qin H, Peterson E, Busath DD, Zhou HX, Cross TA: Insight into the mechanism of the influenza A proton channel from a structure in a lipid bilayer. Science (New York, NY) 2010, 330(6003):509-512.
13. Acharya R, Carnevale V, Fiorin G, Levine BG, Polishchuk AL, Balannik V, Samish I, Lamb RA, Pinto LH, DeGrado WF, et al: Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(34):15075-15080.
14. Hong M, DeGrado WF: Structural basis for proton conduction and inhibition by the influenza M2 protein. Nature 2008, 451(7178):596-599.
15. Pinto LH, Holsinger LJ, Lamb RA: Influenza virus M2 protein has ion channel activity. Cell 1992, 69(3):517-528.
16. McCown MF, Pekosz A: Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production. Journal of virology 2006, 80(16):8178-8189.
17. Ma C, Polishchuk AL, Ohigashi Y, Stouffer AL, Schon A, Magavern E, Jing X, Lear JD, Freire E, Lamb RA, et al: Identification of the functional core of the influenza A virus A/M2 proton-selective ion channel. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(30):12283-12288.
18. Betakova T, Hay AJ: Stability and function of the influenza A virus M2 ion channel protein is determined by both extracellular and cytoplasmic domains. Archives of virology 2009, 154(1):147-151.
19. Roberts KL, Leser GP, Ma C, Lamb RA: The amphipathic helix of influenza A virus M2 protein is required for filamentous bud formation and scission of filamentous and spherical particles. Journal of virology 2013, 87(18):9973-9982.